Defining the high-risk category of patients with cutaneous melanoma: a practical tool based on prognostic modeling
IntroductionAlthough most cutaneous melanoma (CM) in its early stages is treatable, the risk of recurrence remains high and there is a particular ambiguity on patients prognosis. This drives to identification of prognostic biomarkers for predicting CM recurrence to guide appropriate treatment in pat...
Saved in:
Main Authors: | Oleksandr Dudin, Ozar Mintser, Vitalii Gurianov, Nazarii Kobyliak, Denys Kozakov, Sofiia Livshun, Oksana Sulaieva |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2025.1543148/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune cells in thyroid adenoma and carcinoma: uncovering a hidden value of assessing tumor-host interplay and its potential application in thyroid cytopathology
by: Iryna Omelianenko, et al.
Published: (2025-01-01) -
Melanoma genomics – will we go beyond BRAF in clinics?
by: Justyna Mirek, et al.
Published: (2024-09-01) -
Dual role of Cathepsin S in cutaneous melanoma: insights from mendelian randomization and bioinformatics analysis
by: Linsa Zhou, et al.
Published: (2025-01-01) -
Acral Lentiginous Melanoma Presenting with Amelanotic Metastasis
by: Alaka J Mohan, et al.
Published: (2025-01-01) -
Magnolol induces cell death through PI3K/Akt‐mediated epigenetic modifications boosting treatment of BRAF‐ and NRAS‐mutant melanoma
by: Abdullah Al Emran, et al.
Published: (2019-03-01)